11/9/2011

Health Canada said five cases have been reported this year involving a drug mix-up of Pradax, by Boehringer Ingelheim, and Plavix, by Sanofi and Bristol-Myers Squibb, because of their similar trade names. One case resulted in nonserious bleeding after a medical procedure. Taking one drug when the other is prescribed could increase the risk of bleeding, heart attack or blood clots, the health agency said.

Full Story:
CBC.ca (Canada)

Related Summaries